Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Mukka Proteins Annual General Meeting

Mukka Proteins Limited issued a postal ballot notice seeking shareholder approval for a preferential warrant issuance. Voting concludes on July 12, 2026.

Source

NSE filing, NSE: MUKKA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Mukka Proteins Ltd: key numbers

Share price
₹24.19
Market cap
₹725.7 Cr
Revenue (annual)
₹1,449 Cr
Net profit (annual)
₹52.06 Cr
P/E (TTM)
10.5×Sector 26.2×
Promoter holding
73.33%+0.00% QoQ
FII holding
1.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mukka Proteins Ltd

All →
17:46 IST BSE
Regulatory Approval

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution
October 1, 2026 to December 31, 2027

Other annual general meeting announcements

All →